,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-12-01 06:37:00,Coupa Software Inc.COUP is set to release third-quarter fiscal 2018 results on Dec 4.,0.013350766152143478,0.009091338142752647,0.977557897567749,neutral,0.004259428009390831
1,2017-12-01 06:37:00,"The company beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average positive surprise of 37.94%.",0.9489037394523621,0.027594592422246933,0.023501645773649216,positive,0.9213091731071472
2,2017-12-01 06:37:00,"In the preceding quarter, the company delivered a positive earnings surprise of 41.18%.",0.9388166069984436,0.03683100640773773,0.02435237169265747,positive,0.9019855856895447
3,2017-12-01 06:37:00,"Moreover, Coupa beat the Zacks Consensus Estimate for revenues in three of the last four quarters.",0.9518066644668579,0.02394004352390766,0.024253355339169502,positive,0.9278666377067566
4,2017-12-01 06:37:00,"For third-quarter fiscal 2018, revenues are anticipated in the range of $44.8-45.3 million.",0.03689132258296013,0.006745131686329842,0.9563635587692261,neutral,0.030146190896630287
5,2017-12-01 06:37:00,"Subscription revenues are forecast between $40.8 million and $41.3 million, while professional services revenues are projected at approximately $4 million.",0.020110338926315308,0.00822505448013544,0.9716646075248718,neutral,0.011885284446179867
6,2017-12-01 06:37:00,Management projects non-GAAP gross margins between 67% and 69%.,0.029972845688462257,0.015662947669625282,0.9543641805648804,neutral,0.014309898018836975
7,2017-12-01 06:37:00,"Moreover, non-GAAP loss from operations is anticipated in the range of $5.5-$6.5 million.",0.019334513694047928,0.951015830039978,0.02964964509010315,negative,-0.9316813349723816
8,2017-12-01 06:37:00,Net loss is anticipated in the range of 10-12 cents per share.,0.01914885826408863,0.8797993659973145,0.10105185210704803,negative,-0.8606504797935486
9,2017-12-01 06:37:00,"Notably, Coupa's shares have returned 41.7% year to date, slightly better than the 29.8% rally of the industry .",0.9517812728881836,0.028321238234639168,0.019897514954209328,positive,0.9234600067138672
10,2017-12-01 06:37:00,Let's see how things are shaping up for this announcement.,0.04255152866244316,0.005616344977170229,0.951832115650177,neutral,0.03693518415093422
11,2017-12-01 06:37:00,"Coupa provides unified, cloud-based spend management platform that helps enterprises keep a tab of daily expenditures.",0.11424529552459717,0.006089976988732815,0.8796647787094116,neutral,0.10815531760454178
12,2017-12-01 06:37:00,Cumulative spending over the platform since its launch has surpassed $500 billion (at the end of second-quarter fiscal 2018).,0.3042941689491272,0.007720232009887695,0.6879855394363403,neutral,0.2965739369392395
13,2017-12-01 06:37:00,"This reflects growing adoption of its solutions by the likes of Amazon.com Inc AMZN , salesforce CRM , Caterpillar, Unilever and others.",0.8900620937347412,0.012102724984288216,0.09783519059419632,positive,0.8779593706130981
14,2017-12-01 06:37:00,"Moreover, an expanding partner base is expected to drive top-line growth.",0.9235443472862244,0.01421396341174841,0.062241654843091965,positive,0.9093303680419922
15,2017-12-01 06:37:00,"The partnership with Software AG makes it easy for companies to integrate Coupa with most leading enterprise resource planning (ERP) systems, including those from SAP and Oracle.",0.800459623336792,0.012308931909501553,0.18723151087760925,positive,0.7881506681442261
16,2017-12-01 06:37:00,The company has expanded CoupaLink certified solutions by adding Software AG's webMethods Connector.,0.8936848640441895,0.011716604232788086,0.09459855407476425,positive,0.8819682598114014
17,2017-12-01 06:37:00,"In the last quarter, Coupa launched its next-generation cloud platform and added more than 70 new capabilities.",0.7820560932159424,0.010921240784227848,0.20702271163463593,positive,0.7711348533630371
18,2017-12-01 06:37:00,"We believe that the platform will help the company gain new customers rapidly, which will drive result in the soon-to-be reported quarter.",0.9366737008094788,0.01359069999307394,0.04973559454083443,positive,0.9230830073356628
19,2017-12-01 06:37:00,"Moreover, the availability of Coupa Open Buy with Amazon Business in the United States is a growth driver.",0.9331192970275879,0.013856781646609306,0.053023964166641235,positive,0.9192625284194946
20,2017-12-01 06:37:00,"Nevertheless, Coupa is unlikely to deliver a positive earnings surprise in third-quarter fiscal 2018 due to an unfavorable combination of Zacks Rank #3 (Hold) and an Earnings ESP of 0.00%.",0.033066947013139725,0.950206995010376,0.01672602817416191,negative,-0.9171400666236877
21,2017-12-01 06:37:00,"This is because, as per our model, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 for this to happen.",0.4784530997276306,0.014005757868289948,0.5075411796569824,neutral,0.46444734930992126
22,2017-12-01 06:37:00,You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter .,0.04353822022676468,0.005458584520965815,0.9510031938552856,neutral,0.038079634308815
23,2017-12-01 06:37:00,"We don't recommend Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.",0.03763467073440552,0.3271598517894745,0.6352055072784424,neutral,-0.28952518105506897
24,2017-12-01 06:37:00,"Here is a stock you may consider, per our model, which has the right combination of elements to post an earnings beat this quarter.",0.2774152159690857,0.007997579872608185,0.7145872116088867,neutral,0.2694176435470581
25,2017-12-01 06:37:00,Broadcom AVGO has an Earnings ESP of +0.51% and a Zacks Rank #2.,0.3339924216270447,0.021071746945381165,0.6449358463287354,neutral,0.3129206895828247
26,2017-12-01 06:37:00,You can see the complete list of today's Zacks #1 Rank stocks here.,0.028663383796811104,0.01958855800330639,0.9517480134963989,neutral,0.009074825793504715
27,2017-12-01 06:37:00,"Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.",0.7109310626983643,0.014803656376898289,0.274265319108963,positive,0.6961274147033691
28,2017-12-01 06:37:00,New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline.,0.8527401685714722,0.013783727772533894,0.1334761381149292,positive,0.8389564156532288
29,2017-12-01 06:37:00,Early investors could realize exceptional profits.,0.8721199035644531,0.01637672632932663,0.11150334030389786,positive,0.8557431697845459
30,2017-12-01 06:37:00,"Click here to see the 5 stocks >>

Want the latest recommendations from Zacks Investment Research?",0.02363543026149273,0.017521947622299194,0.9588425755500793,neutral,0.006113482639193535
31,2017-12-01 06:37:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
32,2017-12-01 06:37:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
33,2017-12-01 06:37:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
